Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

ALRN-6924 may prevent hair loss caused by chemotherapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

New acne treatments show promise as alternatives to traditional therapies.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

EMT plays a key role in skin fibrosis and offers new therapy targets.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Targeting EGFR may help reduce hair loss from chemotherapy.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Retinoic acid and DMSO improve gene delivery to mouse skin for potential hair and skin disease treatment.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.

New treatments for hair loss show promise with advanced therapies and better targeting.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.